Cargando…

High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer

BACKGROUND: The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are easily obtained from routine blood tests. We investigated the associations of the NLR and PLR with the clinical parameters and prognoses of small cell lung cancer (SCLC) patients. METHODS: Pre-treatment c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Dan, Huang, Yi, Li, Lei, Song, Juan, Zhang, Li, Li, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740933/ https://www.ncbi.nlm.nih.gov/pubmed/29268698 http://dx.doi.org/10.1186/s12885-017-3893-1

Ejemplares similares

High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis
por: Zhang, Jialing, et al.
Publicado: (2021)

Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma
por: Shi, Lihui, et al.
Publicado: (2016)

Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis
por: Jin, Jing, et al.
Publicado: (2020)

Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in non-small cell lung cancer
por: Bayraktaroglu, Mesut, et al.
Publicado: (2023)

High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
por: Ke, Te-Min, et al.
Publicado: (2020)

Pretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer
por: Wang, Xin, et al.
Publicado: (2016)

The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer
por: Kang, M H, et al.
Publicado: (2014)

Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with high myopia
por: Wang, Xin, et al.
Publicado: (2022)

The clinical value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer-to-fibrinogen ratio for predicting pneumonia and poor outcomes in patients with acute intracerebral hemorrhage
por: Luo, Sai, et al.
Publicado: (2022)

Total lymphocyte count, neutrophil–lymphocyte ratio, and platelet–lymphocyte ratio as prognostic factors in advanced non–small cell lung cancer with chemoradiotherapy
por: Song, Xinyu, et al.
Publicado: (2018)

Neutrophil-Lymphocyte Ratio in Small Renal Masses
por: Bazzi, Wassim M., et al.
Publicado: (2014)

Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer
por: Wang, Jun, et al.
Publicado: (2016)

Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
por: Deng, Min, et al.
Publicado: (2017)

Clinical significance of preoperative neutrophil‐lymphocyte ratio and platelet‐lymphocyte ratio in the prognosis of resected early‐stage patients with non‐small cell lung cancer: A meta‐analysis
por: Cao, Weibo, et al.
Publicado: (2022)

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma
por: Lin, Guohe, et al.
Publicado: (2016)

Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Branch Retinal Vein Occlusion
por: Zhu, Dan-dan, et al.
Publicado: (2019)

The prognostic value of neutrophil to lymphocyte and platelet to lymphocyte ratios for patients with lung cancer
por: Wang, Liqun, et al.
Publicado: (2017)

Genotype‐Positive Status Is Associated With Poor Prognoses in Patients With Left Ventricular Noncompaction Cardiomyopathy
por: Li, Shijie, et al.
Publicado: (2018)

Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer
por: Zhang, Yan, et al.
Publicado: (2018)

Tripartite motif-containing 15 overexpression in non-small cell lung cancer is associated with poor patient prognoses
por: Han, Xiaoying, et al.
Publicado: (2019)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
por: Wang, Huan, et al.
Publicado: (2020)

The association between neutrophil–lymphocyte ratio and poor outcomes following infant cardiac surgery
por: Gao, Peng, et al.
Publicado: (2021)

Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients
por: Wu, Guannan, et al.
Publicado: (2015)

Early increased neutrophil-to-lymphocyte ratio is associated with poor 3-month outcomes in spontaneous intracerebral hemorrhage
por: Qin, Jie, et al.
Publicado: (2019)

Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis
por: Peng, You-Fan, et al.
Publicado: (2015)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
por: Xie, Tan, et al.
Publicado: (2023)

Associations of neutrophil-to-lymphocyte ratio with intracranial and extracranial atherosclerotic stenosis
por: Xie, Yu, et al.
Publicado: (2022)

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2019)

Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients
por: Wang, Wen-Ming, et al.
Publicado: (2021)

eIF4E Overexpression Is Associated with Poor Prognoses of Ovarian Cancer
por: Zheng, Jun, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Blood to Distinguish Lung Cancer Patients from Healthy Subjects
por: Zhu, Xuming, et al.
Publicado: (2020)

Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma
por: Lu, Aiying, et al.
Publicado: (2017)

Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Total Lymphocyte Count, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio as Prognostic Factors in Advanced Non-Small Cell Lung Cancer with Chemoradiotherapy [Corrigenudm]
Publicado: (2021)

An Elevated Neutrophil-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Liver Cancer after Interventional Treatments
por: Li, Xiaonan, et al.
Publicado: (2022)

Relationship Between Neutrophil-To-Lymphocyte Ratio and Brain Metastasis in Non-Small Cell Lung Cancer Patients
por: Hu, Chunxiao, et al.
Publicado: (2022)

Prognostic utility of inflammation-based biomarkers, neutrophil–lymphocyte ratio and change in neutrophil–lymphocyte ratio, in surgically resected lung cancers
por: Thompson, Daniel, et al.
Publicado: (2021)

The Associations of Lymphocyte Ratio and Neutrophil Ratio on Liver Dysfunction in COVID-19 Patients
por: Liu, Fang, et al.
Publicado: (2021)

Prognostic value of baseline and change in neutrophil-to-lymphocyte ratio for survival in advanced non-small cell lung cancer patients with poor performance status receiving PD-1 inhibitors
por: Chen, Shixue, et al.
Publicado: (2021)

The clinical relevance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic obstructive pulmonary disease with lung cancer
por: Ma, Aiping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p645sn9chl2k2t9jdge3bei9c5